Clinical trial
Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal…
NCT00226109 · University of Aarhus, Other · Suspended
Key facts
| NCT number | NCT00226109 |
|---|---|
| Title | Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics |
| Official title | Effect of Spironolactone Treatment on Heart- and Skeletal Muscle in Chronic Alcoholics |
| Acronym | SPICA |
| Lead sponsor | University of Aarhus, Other |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiomyopathy, Alcoholic, Alcoholism |
| Intervention type | Drug |
| Interventions | spironolactone |
| Enrollment | 40 |
| Start date | Apr 1, 2004 |
| Primary completion | Aug 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Sep 26, 2005 |
| Last update posted | Oct 20, 2010 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: